Porsolt

Dr. David Pushett has been appointed director of global business development at Porsolt. Dr. Pushett has more than 15 years of biotech research and business experience, including extensive knowledge of the CRO industry, contract negotiations, strategic planning, and technology assessment. He will support the company’s international business development team and identify new and expanding markets.

Dr. Pushett previously served as vice president of business development at PsychoGenics Inc, a preclinical CRO. Prior to that he served as chief operations officer of MindGenix, a CRO focused on preclinical testing services for Alzheimer’s Disease.

“We are extremely excited about David’s appointment. His extensive knowledge and experience in the industry will strengthen Porsolt’s business expansion strategy,” said Dr. Mark Duxon, chief executive officer. “This appointment continues Porsolt’s drive to provide its clients with experienced industry personnel to support their projects.”